← SynDRA
FASORACETAM
SynDRA canonical compound SYN0031942 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | GABBR1 | GABBR2 |
| Mechanism of action | GABA receptor antagonist |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- AEVI-001
- AEVI001
- LAM-105
- LAM-105 ANHYDROUS
- LAM105 ANHYDROUS
- NFC-1 ANHYDROUS
- NFC1 ANHYDROUS
- NS-105
- NS105
- (R)-1-[(5-Oxo-2-pyrrolidinyl)carbonyl]piperidine
- (R)-5-(Piperidin-1-ylcarbonyl)pyrrolidin-2-one
- Fasoracetam [INN]
- (5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one
- N-(5-Oxo-D-prolyl)piperidine
- NS 105 (pharmaceutical)
- NS 105
- (R)-1-((5-Oxo-2-pyrrolidinyl)carbonyl)piperidine
- UNII-42O8UF5CJB
- 2-Pyrrolidinone, 5-(1-piperidinylcarbonyl)-, (5R)-
- (+)-1-(((R)-5-Oxo-2-pyrrolidinyl)carbonyl)piperidine
- Piperidine, 1-((5-oxo-2-pyrrolidinyl)carbonyl)-, (R)-
- DTXCID6028781
- (5R)-5-(1-piperidinylcarbonyl)-2-pyrrolidinone
- (r)-1-[(5-oxo-2-pyrrolidinyl)carbonyl]piperidine
- fasoracetamum
- RefChem:140004
- (R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one
- NCGC00182992-01
- MFCD00875708
- SCHEMBL194770
- orb1220083
- CHEBI:31592
- EX-A736
- Tox21_113340
- AKOS006280726
- AC-31949
- BS-49484
- Fasoracetam ;aka NS-105 ;LAM-105)
Look up FASORACETAM in the interactive SynDRA portal →